DECIPHERA
Live / Registered — Registered (as of 07 May 2024)
What this means for you
Registered since 07 May 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97894977
- Registration number
- 7380005
- Mark type
- Stylized text
- Filed
- 18 Apr 2023
- Published for opposition
- 20 Feb 2024
- Registered
- 07 May 2024
- Attorney of record
- Jessica L. Rothstein
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical oncology treatments, namely, preparations for gastrointestinal stromal tumors, systemic mastocytosis, glioma, non-small cell lung cancer, germ cell cancer, penile cancer, melanoma and soft tissue sarcoma
- Class 042 — Scientific and technological services: pharmaceutical research and development; providing scientific research information in the field of pharmaceuticals and clinical trials
- Class 044 — Medical, beauty and agricultural services: medical services, namely, medical treatment for gastrointestinal stromal tumors, systemic mastocytosis, glioma, non-small cell lung cancer, germ cell cancer, penile cancer, melanoma and soft tissue sarcoma
Owner
- Deciphera Pharmaceuticals, LLC, Waltham, MA, US
- Deciphera Pharmaceuticals, LLC, Waltham, MA, US
- Deciphera Pharmaceuticals, LLC, Waltham, MA, US
Prior registrations
Prosecution history
- 07 May 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 07 May 2024 — REGISTERED-PRINCIPAL REGISTER
- 04 Mar 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 20 Feb 2024 — PUBLISHED FOR OPPOSITION
- 02 Feb 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 01 Feb 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 01 Feb 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 13 Jan 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 12 Jan 2024 — ASSIGNED TO EXAMINER
- 14 May 2023 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 21 Apr 2023 — NEW APPLICATION ENTERED